|Bid||11.70 x 800|
|Ask||12.61 x 3200|
|Day's range||12.48 - 12.79|
|52-week range||10.10 - 22.40|
|Beta (5Y monthly)||1.39|
|PE ratio (TTM)||N/A|
|Earnings date||03 Nov 2021 - 08 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||33.00|
One thing we could say about the analysts on Heron Therapeutics, Inc. ( NASDAQ:HRTX ) - they aren't optimistic, having...
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -5.08% and -21.08%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...